News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,171 Results
Type
Article (2580)
Company Profile (45)
Press Release (37545)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14213)
Career Advice (78)
Deals (2112)
Drug Delivery (9)
Drug Development (4153)
Employer Resources (10)
FDA (443)
Job Trends (783)
News (20306)
Policy (1060)
Tag
Academia (145)
Allergies (7)
Alliances (3507)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (447)
Artificial intelligence (32)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (477)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (44)
Cancer (324)
Cardiovascular disease (10)
Career advice (66)
Career pathing (1)
CAR-T (31)
CDC (1)
Cell therapy (81)
Cervical cancer (2)
Clinical research (3446)
Collaboration (199)
Company closure (2)
Compensation (104)
COVID-19 (185)
CRISPR (11)
C-suite (113)
Cystic fibrosis (7)
Data (419)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (488)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (37)
Drug pricing (10)
Duchenne muscular dystrophy (40)
Earnings (4505)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6402)
Executive appointments (135)
FDA (590)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (168)
Gene editing (32)
Generative AI (1)
Gene therapy (55)
GLP-1 (63)
Government (159)
Guidances (24)
Healthcare (711)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (4)
Infectious disease (197)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (25)
Interviews (7)
IPO (1004)
IRA (7)
Job creations (293)
Job search strategy (62)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (318)
Medtech (319)
Mergers & acquisitions (1223)
Metabolic disorders (72)
Multiple sclerosis (22)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (164)
NextGen: Class of 2026 (353)
Non-profit (155)
Now hiring (11)
Obesity (32)
Opinion (17)
Ovarian cancer (17)
Pain (24)
Pancreatic cancer (21)
Parkinson's disease (11)
Partnered (4)
Patents (53)
Patient recruitment (26)
Peanut (1)
People (5878)
Pharmaceutical (5)
Phase 1 (1477)
Phase 2 (1708)
Phase 3 (919)
Pipeline (390)
Policy (16)
Postmarket research (30)
Preclinical (640)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (14)
Rare diseases (64)
Real estate (425)
Recruiting (5)
Regulatory (920)
Reports (7)
Research institute (149)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (47)
Series B (20)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (497)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (52)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Last 7 days (39)
Last 30 days (137)
Last 365 days (2412)
2026 (211)
2025 (2439)
2024 (2618)
2023 (2861)
2022 (3755)
2021 (4052)
2020 (3474)
2019 (2066)
2018 (1554)
2017 (1800)
2016 (1626)
2015 (1840)
2014 (1374)
2013 (1192)
2012 (1399)
2011 (1335)
2010 (1185)
Location
Africa (44)
Alabama (3)
Arizona (18)
Asia (1965)
Australia (310)
California (1601)
Canada (241)
China (80)
Colorado (54)
Connecticut (16)
Delaware (5)
Europe (4026)
Florida (64)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (2)
Indiana (60)
Japan (20)
Kansas (14)
Kentucky (1)
Maryland (49)
Massachusetts (568)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (133)
New York (80)
North Carolina (131)
Northern California (781)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (109)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (652)
Tennessee (4)
Texas (152)
United States (3203)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,171 Results for "senda biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Senda Biosciences Appoints Igor Matushansky as Chief Medical Officer
Senda Biosciences, Inc. today announced the appointment of Igor Matushansky, M.D., Ph.D., as Chief Medical Officer.
July 24, 2023
·
5 min read
Business
Senda Biosciences Appoints Marc Wolfgang as Senior Vice President, Manufacturing
Senda Biosciences, Inc., a Flagship Pioneering company pioneering programmable medicines, announced the appointment of Marc Wolfgang as Senior Vice President, Manufacturing.
June 12, 2023
·
3 min read
Deals
Flagship’s Laronde, Senda Form Company Focused on New Class of Medicines
Sail Biomedicines combines Laronde’s circular eRNA platform with Senda’s nanoparticle delivery technology in the pursuit of a new class of programmable medicines across therapeutic areas.
October 20, 2023
·
2 min read
·
Tristan Manalac
Business
Senda Biosciences Bolsters Executive Leadership Team
Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent, and tunable medicines, today announced the appointments of Lori Rudolph-Owen, Ph.D., as Chief Operating Officer, and Barbara Bispham, J.D., as SVP, General Counsel.
October 19, 2022
·
4 min read
Business
Senda Biosciences Appoints Luke O’Neill, Ph.D., as Chief Scientific Officer
Senda Biosciences, Inc., a company harnessing nature to enable the world’s first comprehensive programming of medicines, today announced the appointment of Luke O’Neill, Ph.D., as Chief Scientific Officer.
January 12, 2023
·
3 min read
Business
Senda Biosciences Appoints MIT Institute Professor Paula Hammond, Ph.D., to Its Board of Directors
Senda Biosciences, Inc. announced the appointment of Paula Hammond, Ph.D., Institute Professor and Head of MIT’s Department of Chemical Engineering, to the Company’s Board of Directors.
December 14, 2022
·
4 min read
Genetown
Senda Biosciences Announces Close of $123 Million Series C Financing
Senda Biosciences , Inc., a company that is harnessing nature to program targeted, potent, and tunable medicines, today announced the completion of a $123 million Series C financing, bringing its total funding raised to date to $266 million.
August 16, 2022
·
4 min read
Business
Senda Biosciences Scores $226M to Advance Programmable Medicines Platform
Proceeds from the fund activities will be used to back Senda’s proprietary programmable medicines platform and advance its projects to clinical trial stages.
August 16, 2022
·
2 min read
·
Vanessa Doctor, RN
Press Releases
Change in Number of Shares and Votes in Alligator Bioscience AB
February 1, 2026
·
1 min read
Press Releases
Imbed Biosciences Secures Strategic Investment from BioLab Holdings
February 4, 2026
·
2 min read
1 of 4,018
Next
